Myasthenia Gravis in Pregnancy and the Newborn

Abstract

While rare, MG is a complex disease with multiple effects on pregnancy. Medications for treating symptoms can affect the pregnancy and developing fetus. The presence of autoantibodies and their ability to cross the placenta should prompt clinicians to closely monitor infants with a birth parent affected by MG to assess for any development of TNM. While symptoms of TNM can be mild and self-resolve, treatment may be warranted in severe cases of respiratory compromise.